Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome

Clinical trial NCT00316550 · TERMINATED

Trial details

NCT number: NCT00316550
Sponsor: Avera Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2006-04-01
Primary completion: 2007-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.